WallStSmart

Churchill Capital Corp XI (CCXI)vsITHAX Acquisition Corp III Class A Ordinary Shares (ITHA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ITHA leads profitability with a 0.0% profit margin vs 0.0%. ITHA earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

ITHA

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

ITHA0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$804.87M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

ITHA4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$307.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : ITHA

ITHA has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : ITHA

The primary concerns for ITHA are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

ITHA is growing revenue faster at 0.0% — sustainability is the question.

ITHA generates stronger free cash flow (-88,730), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

ITHAX Acquisition Corp III Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

ITHAX Acquisition Corp III is a special purpose acquisition company (SPAC) focused on merging with high-growth entities in the technology, media, and telecommunications sectors. With an experienced leadership team, ITHAX strategically targets transformative businesses poised for significant growth, aiming to leverage market opportunities and foster innovative partnerships. The company is committed to a disciplined acquisition strategy designed to enhance shareholder value, positioning itself to deliver robust returns in a rapidly evolving tech ecosystem. As it navigates the dynamic landscape, ITHAX remains poised to capitalize on emerging trends and drive sustainable growth for its investors.

Want to dig deeper into these stocks?